|
US7223739B1
(en)
|
1995-06-07 |
2007-05-29 |
Powderject Vaccines, Inc. |
Adjuvanted genetic vaccines
|
|
US7294338B2
(en)
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
FR2751227B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
|
CA2223029A1
(en)
*
|
1997-02-12 |
1998-08-12 |
Akzo Nobel Nv |
Canine parvovirus dna vaccines
|
|
EP0863151A1
(en)
*
|
1997-02-12 |
1998-09-09 |
Akzo Nobel N.V. |
"Canine parvovirus dna vaccines"
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AU753688B2
(en)
*
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
ATE376062T1
(de)
|
1997-08-04 |
2007-11-15 |
Cell Genesys Inc |
Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung
|
|
WO1999019471A1
(en)
|
1997-10-16 |
1999-04-22 |
Board Of Regents, The University Of Texas System |
Models and treatments for cardiac hypertrophy in relation with nf-at3 function
|
|
NZ504894A
(en)
*
|
1997-12-02 |
2002-12-20 |
Powderject Vaccines Inc |
Crystalline vaccine and adjuvant compositions jointly and separately administered to animals using a transdermal or transmucosally delivery technique
|
|
ATE305507T1
(de)
*
|
1998-05-14 |
2005-10-15 |
Coley Pharm Gmbh |
Verfahren zur regulierung der hematopoiese mit hilfe von cpg oligonukleotide
|
|
US6881723B1
(en)
|
1998-11-05 |
2005-04-19 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
AU3593200A
(en)
|
1999-02-09 |
2000-08-29 |
Powderject Vaccines, Inc. |
(mycobacterium tuberculosis), immunization
|
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
US6852705B2
(en)
|
2000-01-21 |
2005-02-08 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
US7078388B2
(en)
|
2000-01-21 |
2006-07-18 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
CA2868618C
(en)
*
|
2002-10-16 |
2017-05-23 |
Gen-Probe Incorporated |
Compositions and methods for detecting west nile virus
|
|
US7927840B2
(en)
|
2006-09-11 |
2011-04-19 |
Gen Probe Incorporated |
Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
|
|
JP4850512B2
(ja)
*
|
2003-05-15 |
2012-01-11 |
独立行政法人科学技術振興機構 |
免疫刺激剤
|
|
JP4817599B2
(ja)
*
|
2003-12-25 |
2011-11-16 |
独立行政法人科学技術振興機構 |
免疫活性増強剤とこれを用いた免疫活性の増強方法
|
|
CA2623106C
(en)
|
2005-09-19 |
2013-12-24 |
Histogenics Corporation |
Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
|
|
ATE479439T1
(de)
*
|
2007-12-28 |
2010-09-15 |
Deutsches Krebsforsch |
Parvovirus mit cpg-angereichertem genom zur krebstherapie
|
|
WO2013163606A1
(en)
|
2012-04-27 |
2013-10-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Vascular endothelial growth factor antagonists and methods for their use
|
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|